Intrinsic Value of S&P & Nasdaq Contact Us

Palisade Bio, Inc. PALI NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
34/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.50
-27.2%

Palisade Bio, Inc. (PALI) has 12 identified peers for comparison in the Healthcare sector. Peers include APGN, CYTO, EFTR, ENVB, IMMX, NAVB and others.

PALI has a market capitalization of $341.72M, compared to an average peer market cap of $93.46M. PALI is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message